TNGX – tango therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock.
Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
MEDIVIR AB - INTERIM REPORT JANUARY - MARCH 2024 [Yahoo! Finance]
Tango Therapeutics, Inc. (NASDAQ: TNGX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Form 10-Q Tango Therapeutics, Inc. For: Mar 31
Form 8-K Tango Therapeutics, Inc. For: May 08
Form 4 Tango Therapeutics, Inc. For: May 01 Filed by: Davis Aaron I.
Form 144 Tango Therapeutics, Inc. Filed by: MVA Investors, LLC
Form 144 Tango Therapeutics, Inc. Filed by: MVA Investors, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.